When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cellulitis and erysipelas

Last reviewed: 23 Jun 2024
Last updated: 27 Sep 2022

Summary

Definition

History and exam

Key diagnostic factors

  • skin discomfort
  • macular erythema
  • disruption of cutaneous barrier
  • raised bright-red erythema with clearly demarcated margins (erysipelas)
  • risk of infection with MRSA
Full details

Other diagnostic factors

  • history of diabetes
  • constitutional prodrome
  • lymphangitis/regional lymphadenopathy
  • Identifiable port of entry
  • history of immunocompromise
  • unusual exposure (salt or fresh water, bite)
Full details

Risk factors

  • prior episode of cellulitis
  • diabetes
  • ulcer/wound
  • dermatosis
  • tinea pedis interdigitalis
  • lymphedema
  • venous insufficiency/chronic leg edema
  • overweight
Full details

Diagnostic tests

1st tests to order

  • CBC
  • purulent focus culture and molecular diagnostic procedures
Full details

Tests to consider

  • skin aspiration with culture and molecular diagnostic procedures
  • blood culture
  • skin biopsy
  • plain film x-ray
  • ultrasound
  • CT scan
  • MRI
Full details

Treatment algorithm

ACUTE

mild

moderate

severe

ONGOING

treatment failure

frequent relapses

Contributors

Authors

Arash Mostaghimi, MD, MPA, MPH

Assistant Professor of Dermatology

Harvard Medical School

Director, Inpatient Consultation Service

Department of Dermatology

Brigham and Women’s Hospital

Boston

MA

Disclosures

AM declares no competing interests relating to work on skin and soft tissue infections. AM has received consulting fees (Pfizer, Hims, Digital Diagnostics, Concert, Lilly, and Abbvie) relating to alopecia research. AM has received equity (Hims), licensing/royalty fees (Pfizer, Concert) for alopecia associated products; clinical trials support (Lilly, Concert). AM is on a medical advisory board (Hims) and is associate editor JAMA Dermatology.

Acknowledgements

Dr Arash Mostaghimi would like to gratefully acknowledge Dr Matthew C. Robinson, the previous contributor to this topic.

Disclosures

MCR declares that he has no competing interests.

Peer reviewers

Robert W. Bradsher, MD

Ebert Professor of Medicine

Director

Division of Infectious Diseases

University of Arkansas for Medical Sciences

Little Rock

AR

Disclosures

RWB declares that he has no competing interests.

Jorg Ruhe, MD, MPH

Assistant Attending

Beth Israel Medical Center

New York

NY

Disclosures

JR declares that he has no competing interests.

  • Differentials

    • Necrotizing fasciitis
    • Thrombophlebitis, superficial
    • Deep vein thrombosis
    More Differentials
  • Guidelines

    • 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections
    • Practice guidelines for the diagnosis and management of skin and soft tissue infections
    More Guidelines
  • Patient information

    Cellulitis and erysipelas

    More Patient information
  • Videos

    Venepuncture and phlebotomy: animated demonstration

    Peripheral intravascular catheter: animated demonstration

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer